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Hydrogels made  of  chitosan  has  a  well‐established  place  in  drug  delivery  for  the 
skin. Our particular interest were hydrogels for wound healing. Hydrogels from low, 
medium and high molecular weight were prepared  in different  concentrations  for 
texture and release characterization incorporating  liposomes and chloramphenicol 
as a model drug.  







freeze‐thaw  test.  Stability was  improved with  glycerine  in  the  hydrogels.  Stability 





















1. General introduction  
 
Wounds are injury to tissue in which the skin is torn, punctured or cut. Blunt force trauma 
can also cause a contusion. Burn wounds can affect several skin layers and can be hard to 
treat. Chitosan gels can act as dressing for wounds keeping it moist and remove unwanted 
extrudates from the damaged skin. Hydrogels made of chitosan polymers can function as 
a scaffold, helping degenerate skin structure. The chitosan molecule has positively 
charged deacetylated aminogroups that can have an antimicrobial effect. Drugs can be 
incorporated in the gel matrix, or inside liposomes dispersed into the hydrogel for 
controlled localized delivery. 
Hydrogels are cross-linked polymers with many hydrophilic side groups. This feature 
gives polymer the capability to bind water in larger quantities than its own weight. The 
forces between the polymer strains keep the gel from dissolving. 
Chitin is the bricks of chitosan and is the second most abboundant carbohydrate found in 
nature. Chitosan is generally safe for human use because of its biodegradability and non-













The term chitosan is used to describe a series of polymers of different degree of 
deacetylation (DD), defined as percentage of primary aminogroups in the polymer 
backbone and average molecular weight (Figure 1; George and Abraham, 2006). 
Chitosan is a semi synthetic copolymer made by deacetylation of chitin. Chitin, a 
component in the exoskeleton of crustaceans, crabs and some insects, is a natural 
carbohydrate obtained from shellfish. The copolymer polysaccharide is consisting of β-
(1-4)-linked 2 amino-2-deoxy-D-glucose and 2-acetamidoamino-deoxy-D-glucose 
(Berger et al., 2004). The main parameters influencing the chemical characteristics of 
chitosan are its molecular weight and degree of acetylation. 
 
 
FIGURE 1: CHEMICAL STRUCTURE OF CHITOSAN (GEORGE AND ABRAHAM, 2006) 
According to Takahashi et al. (2005) commercially available chitosans, namely low 
molecular weight (LMW), medium molecular weight (MMW), high molecular weight 
(HMW) vary in the degree of deacetylation from 83 – 90 % (Table 1). The degree of 
deacetylation is an important feature when using chitosan as a dressing for wound 
treatment (Berger et al., 2004).  
 
2 
TABLE 1: MEAN MOLECULAR WEIGHT AND DEGREE OF ACETYLATION (TAKAHASHI ET AL., 2005)  
Chitosan Mean MW (g/mol) DD (%) 
Low molecular 3,89*105 83,4 
Medium molecular 5,59*105 83,1 
High molecular 1,24*106 86,6 
Chitin 3,96*105 1,1 
 
Chitosan molecules are quite large polymers. High molecular weight (HMW) chitosan 
can hold more water in a hydrogel than a low molecular weight (LMW). The higher 
weights can also be prepared at lower concentrations than lower molecular weight 
chitosan and obtain the same viscosity. Even the chitosans from the same manufacturer 
have been reported to vary in molecular weight from batch-to-batch (Alsarra, 2009). 
Degree of deacetylation (DD) is a property important when anticipating to what extent 
the hydrogel will be accelerating wound healing. Deacetylating of a chitosan molecule 
results in appearance of amino groups, and the substance achieves the ability to form 
bonds or interacts with other molecules. Amino groups can have an antimicrobial effect. 
High DD can therefore be a desired feature when preparing gels for wound treatment 
(Berger et al., 2004). 
Chitosan is soluble in weak acids such as acetic acid and insoluble in organic solvents 




.1.2. Biodegradation, biodistribution and toxicity 
Chitosan and biodegradation 
Chitosan is generally considered safe for use in pharmaceutical preparations. The 
chitosan gel has been used as the carrier for various drugs and route of drug 
administration (Kean and Thanou, 2010). When applying chitosan in vivo it is important 
to determine its rate of distribution. For that purpose, radio or fluoerescent labelling can 
be applied (Kean and Thanou, 2010) 
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Metabolism should be considered when assessing potential toxicity of chitosan. If 
chitosan undergoes systemic absorption, high molecular weight can possibly rule out 
renal clearance. Molecules with molecular weight above 20000 g/mol can be filtered 
unhindered by kidneys (Rowland and Tozer, 2010) If Mw is larger than the kidneys can 
filtrate, the chitosan polymer should undergo enzymatic metabolism or some form of 
chemical degradation. The most common degradation of chitosan in vivo is considered to 
be lysozymal degradation, and by the bacterial enzymes in the colon (Kean and Thanou, 
2010). 
 
In humans, specific chitinases can hydrolyse chitin derivates. Kean and Thanou (2010) 
suggested that eight of these have been identified and three have shown activity. All of 
these enzymes are in the glycoside hydrolase 18-family. The three enzymes that are 
active against chitin derivates are acidic mammalian chitinase (AMCase), di-N-
acetylchitobiase and chitotriosidase. The three enzymes are metabolizing different kinds 
of chitin structures and are found in lungs, liver and plasma, respectively. It has not yet 
been proven that these enzymes are active when metabolising chitosan polymers. 
Chitinases are more abundant in microorganisms than in humans. Most of the chitinases 
hydrolyse N-acetyl-β-1,4-glucosaminide bonds. This suggests some kind of defence 
mechanism against microbes and insects, which have chitin structure. The microbacterial 





FIGURE 2: ENZYME SPECIFICITY (WWW.SIGMAALDRICH.COM) 
Chitases are chitinases that degrade chitin (Figure 2). They can act both as endo- and exo-
chitinases. Hydrolysis of the glyucosamine-glucoseamine-glucosamine-N-acetyl-
glucosamine and N-acetyl-glusosamine-N-Nacetyl-glucosamine bonds are one form of 
enzymatic degradation (Figure 3).  
 
FIGURE 3: N-ACETYL-GLUCOSAMINE (GLCNAC) (KEAN AND THANOU, 2010) 
The acidic environment in the stomach will cause an acidic degradation. Other common 
chemical degradation will not contribute significantly to the elimination of chitosan 
(Kean and Thanou, 2010). 
Studies in vitro have shown that lysozyme can degrade chitosan. The studies where 
conducted at 37 °C with a phosphate buffer at pH 5.5. The tested chitosan preparation had 
a 66% loss in viscosity after 4 hours. The degree of acetylation had a great influence on 
the loss of viscosity. The more chitosan resemble chitin the more rapid the degradation 
was observed. Covalent bonds and thiol bonds contribute to a more stabile conformation 
and hence a slower degradation (Kean and Thanou, 2010). 
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After four different formulations of chitosan containing a pituitary adenylate cyclase 
activating polypeptide were administered to pigs, limited degradation of chitosan was 
observed. These specific formulations might have the capacity of replacing insulin 
treatment with diabetes patients. The formulations were chitosan with Mw at 400 kDa or 
a modified derivative, chitosan-4thiobutylamine. The chitosan formulation was also 
given by buccal administration and the polymer tolerated 6 hours without disintegrating 
(Kean and Thanou, 2010). 
When assessing biodegradation of chitosan there are some important features to be 
evaluated. That is molecular weight, degree of acetylation, enzyme’s affinity for chitin 
groups and chemical structure with focus on substitution of the N-groups. The amine in 
chitosan has a pKa of 6,3. The cationic part of chitosan needs to be protonated by a weak 
acid like: formate, acetate, lactate, malate, citrate, glyoxylate, pyruvate, glycolate or 
ascorbate (Bhatterai et al, 2010). When preparing formulations of chitosan as a carrier in 
drug delivery systems or chitosan as a topical skin delivery system, these parameters can 
redict how stable and effective the formulation will be (Muzzarelli et al., 2007).  p
 
Biodistribution of chitosan 
The total molecular size and the charge of the side groups will decide chitosan kinetics 
fate in vivo. This is crucial when planning a specific release rate of drugs from chitosan 
formulations by per oral administration. Release can be predicted to some extent when 
anticipating how the chitosan formulations will degrade in vivo. Even when 
administrating chitosan preparations via epicutaneous route, chitosan can be expected to 
undergo partial systemic absorption after application to target tissue. This is more likely 
when applying to damaged skin such as after burns or tissue injury. Chitosan tend to dry 
out after application and some decomposition will occur. This administration route is not 
widely studied in regard to biodistribution (Kean and Thanou, 2010). 
 
Intracellular distribution of chitosan has been studied by using chitosan derivate. A 
chitosan/DNA formulation showed in in vitro conditions that the uptake was three times 
higher at 37 °C than at 4 °C (Kean and Thanou, 2010).  
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Toxicity of chitosan 
Chitosan is regarded as biodegradable and non-toxic. In Finland, Italy and Japan the 
government has accepted chitosan for dietary use. The FDA in the USA has approved 
chitosan for use in wound dressings (Kean and Thanou, 2010).  
Most studies on chitosan toxicity showed little toxicity of chitosan and many of its 
derivatives. However, not all formulations are non-toxic. Kean and Thanou (2010) 
described chitosan HCl salt-derivatives as being be quite toxic. Keong and Halim (2009) 
indicated that additives and impurities when preparing chitosan gels can contribute to its 
toxicity. 
When the DD is high the toxicity is dependent on molecular weight and with low DD the 
molecular weight does not influence the toxicity. The trimethyl derivate (oligomer at 3-6 
kDa) of chitosan showed increasing toxicity with higher degree of trimethylation and 
increasing molecular weights. Relative charge and density will decide chitosan toxicity in 
vivo (Kean and Thanou, 2010). 
Chitosan preperations can be toxic to bacteria, fungi and parasites. Bacterial inhibition 
can be utilized in wound healing. DD at 87% and Mw at 87kDA were more effective 
against Pseudomonas aeruginosa and Staphylococcus aureus than DD at 73% and Mw at 
532 kDa. The two chitosans in a form of an emulsion had effect on Candida albicans and 
Aspergillus niger. A chitosan excipient (meglumine antimoiate) showed anti parasitic 
effect against Leishmania infantum (Kean and Thanou, 2010). 
One 65 days study indicated that there was no toxicity from injected chitosan 
oligosaccharides. The doses were 7,1-8,6 mg/kg over 5 days. Lysozyme activity 
increased as expected. This indicated that lysozymes are indeed effective in chitosan 
degredation. Lethal dose when was found to be 50 mg/kg. Injection of chitosan-
166Holmium proved to be safe in treatment of cancer (Kean and Thanou, 2010). 
 
Chitosan have been used for fat chelation at dose of 4,5g/day and no toxicity for humans 
was reported. However, the influence on weight loss is debatable. Administration of 
trimethyl chitosan/pDNA caused light diarrhea at high doses. Chitosan have little 
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cytototoxicty against human lymphoblastic leukaemia or human embryonic lung cell. 
(Kean and Thanou, 2010).  
 
 
2.1.3. Applications in pharmaceutics 
Hydrogels can act as artificial extracellular matrix (ECM) for tissue rebuilding. Original 
ECM can be regarded as a natural hydrogel. Synthetic hydrogels cannot readily function 
as a support and interact with cells in vivo. This enables hydrogels to serve as building 
blocks for tissue rebuilding in wound healing (Jia and Kiick, 2009). 
Hydrogels can act as vehicle for drugs in several ways. With direct addition of drugs the 
active substance can be encapsulated during the polymers cross-linking. Active 
ingredients can also be diffused into the pores of the hydrogel after swelling. These 
methodes are the simplest but the release rate is hard to control (Bhatterai et al, 2010). 
Release from hydrogels can be categorized as diffusion-controlled, swelling-controlled or 
chemically-controlled. Diffusion-controlled is release from the cross-linked matrix. The 
matrix can be from 5-100 nm. Drugs will often be small molecules. Peptide drugs will 
have therefore a more retarded and prolonged release. Chemically-controlled release is 
characterized by the drugs detached from the gel by some kind of chemical reaction 
within the gel (Bhattarai et al., 2010; Jagur-Grodzinski, 2010). 
Micro and nano capsules can be incorporated into the hydrogel for a more controlled and 
retarded release. Growth factors (example: EGF, TGF-β1) release can be regulated with 
gelatine particles. This can give a controlled release (Bhatterai et al., 2010, Huang and 
Fu, 2010). 
Small covalently attached molecules can have a fairly controlled release since the release 
is controlled by the disintegration of the hydrogel or hydrolysis. Paclitaxel 
(chemotherapeutic), dexamethasone (steroid) and fluvastatin (cholesterol lowering drug) 
are quite small and have successfully been covalently attached to hydrogel polymers. The 
release is not controlled but retarded with this method (Bhatterai et al., 2010). 
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Chitosan hydrogels have been used in liquid gels, powders, beads, films, tablets, 
capsules, microsphares, microparticles, sponges, nanofibrils, textile fibers and even 
inorganic composites (Denkbaş and Ottenbrite 2006; Bhattarai et al., 2010). 
 
2.2. Skin and wounds 
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.2.1. Skin structure 
The skin is covering most of the outer body varying in its thickness and structure. The top 
layer of skin is the epidermis. Cells in epidermis proliferate and renew the layer regularly. 
This is important since the skin is the main barrier protecting the body from damaging 
factors. The underlying layer is the dermis. The dermis is tough for support and nourish 
the skin. Fibroelastic tissue is providing the skin its form. Dermis can be regarded as two 
zones. The upper layer is the thin papillary dermis, and the lower layer the reticular 
dermis. The deepest layer is the hypodermis. Hypodermis is varying the most, with 
mainly adipose tissue. Sweat glands, hair follicles, sebaceous glands and nerve fibers 
intersect all skin layers (Figure 4). Epidermis is considered avascular but the dermis is 
vascular. This means that epidermis is highly dependent on proper blood flow for its 




FIGURE 4: SKIN STRUCTURE (BRITANNICA CONCISE ENCYCLOPAEDIA, 2010) 
 
2.2.1.1. Intact skin  
Covering the body as barrier for chemicals and ultraviolet light, skin also serves as a 
shield for microorganisms and protects from mechanical tear. Thermoregulation is highly 
dependant on the blood flow to the skin. Vitamin D is synthesised in the epidermis. 
Adipose tissue is metabolized into an energy source when needed. The skin is also 
important for our appearance and communication. Healthy skin has numerous properties 












FIGURE 5: DIFFERENT ROUTES OF PENETRATION THROUGH THE SKIN (BENSON, 2005) 
Intracellular route is considered to be the most significant route for permeation of most 
drugs administrated to the skin. Most molecules will penetrate the skin via the lipid 
domains and the degree of lipophilicity will play the dominant role. Small portions of 
drugs (about 0.1%) will possible penetrate via appendages (Figure 5; Benson, 2005). 
 
2.2.1.2. Damaged skin and barrier properties 
Damaged skin can severely reduce quality of life and cause unwanted health problems 
when left untreated. Burns, diabetic ulcers, arterial and venous ulcers can all be challenge 
to treat. When circulation is reduced, blood flow lowered or dermis damaged, the wound 
healing takes longer time and the wound might evolve into a chronic one (Bao et al., 
2009).  
In regard of development of drug delivery system for damaged skin, the changed barrier 
function needs to be taken into consideration. pH of the skin is altered. Lipophilic and 
hydrophilic properties of the skin are most likely different from healthy skin. 
Permeability of drugs might be unexpectedly high or even low. Atrophy due to 
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degeneration of cells will make drug therapy regimes more difficult to design because of 
the reduced thickness of the skin (Boateng et al., 2008). 
 
2.2.2. Wounds and treatment  
Wounds can be classified into chronic wounds and acute wounds. Chronic wounds take 
longer than 8-12 weeks to heal. Examples include diabetic leg ulcers, arterial and venous 
leg ulcers and pressure sores. Acute wounds can be burn wounds, surgical wound or 
wounds from trauma (Chaby et al., 2009; Frankel et al., 2009). 
Skin wounds can be also classified according to the number of skin layers that are 
affected. Superficial wounds are the damage to the epidermis alone. Partial thickness 
wounds are the damage to the epidermis and deeper layers, blood vessels, hair follicles 
and sweat glands. Full thickness wounds are the damage to fat or deeper tissue as well 
(Helms et al., 2006). 
Wounds require good blood flow and good access to rich blood with oxygen in order to 
heal. Dietary nourishment is important for rapid recovery. Healing can be impaired by 
low oxygen flow, infection or malnutrition (Chaby et al., 2009). 
Our particular interest was burns. The healing of burn wounds is a complex physiological 
process that involves migration, proliferation and differentiation of a variety of cell types 




FIGURE 6: WOUND REPAIR (SHAW AND MARTIN, 2009) 
 
Wound healing has four different stages: Inflammation, migration, proliferation, and 
maturation (Figure 6). When skin surface has gained its natural form and strength, the 
healing is considered to be finished (Boateng et al., 2008; Keong and Halim, 2009). 
Inflammation is the body’s reaction to injury. This is the first step of healing and happens 
a few minutes after injury and lasts up to more than 24 hours. The wound is red, painful 
and moist under inflammation. Mediators like cytokine and histamine are released to the 
inflammation site and results in vasodilatation increased capillary permeation and 
stimulation of pain receptors. Exudates of cells, proteins and fibrinogen are playing an 
important role in activating clotting mechanism in the wound causing the bleeding to stop 
(Shaw and Martin, 2009). Migration involves transporting growth factors in the exudates 
and promotes movements of epithelial cells, fibroblasts and keratinocytes to the injured 
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area to renew damaged tissue. Cells grow over the wound, under the dried scab and 
gradually thicken the epithelial layer. This step lasts 2-3 days (Helms et al., 2006). 
Proliferation starts more or less with migration or just after the migration phase. In this 
phase granulation tissue is formed when new capillaries are transporting blood and 
nutrients to the wound. Collagen network are synthesized by fibroblasts. When this 
network is formed, the skin regains its tensile strength. With further proliferation 
epithelial cells migrate through the wound and the wound contracts and closes. In the 
proliferation phase the wound is red and can be moist but not exuding. Proliferation can 
last 5-20 days (Helms et al., 2006). 
Maturation is the last step of wound healing. Collagen fibers are strengthening the skin 
and more capillaries are increasing the blood flow to the wound. This phase can take 
from 3 weeks to 2 years. The final scar is commonly not as strong as the skin was before 
injury, but 70-90% of tensile strength can be expected (Keong and Halim, 2009). These 
processes are regulated by growth factors. Accelerated wound healing can be dependent 
on inducing and activating cytokines and growth factors (Bao et al., 2009). 
Frankel et al. (2009) conducted a microbial study evaluating a presence of 
microorganisms in the wound and found that methicillin resistant S aureus (MRSA) 
strains were very common. B Streptococcus was frequently found, and especially in 
diabetic elderly patients. Other pathogenic bacteria were also found (Acinetobacter 
baumannii, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Klebsiella 
oxytoca, Klebsiella pneumoniae, Proteus vulgaris, Seratia marcescens, Streptococcus 
pneumoniae and Streptococcus pygones). The study confirmed that wounds are highly 
susceptible to infections and that inclusion of antimicrobial agent in wound dressing is 
recommended. 
 
Larger wounds need some kind of cover to help healing. Bandages are widely used for 
wound cover. Hydrogels can function as a film on wounds and in addition keep the 
wound moist. Hydrogels can be washed off by water when change is needed. This will 
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keep the newly made granulation tissue more intact than when removing a dry bandage 
(Chaby et al., 2007). 
The meta-analysis study regarding the use of dressing for acute and chronic wounds 
including hydrocolloids, hydrocellular foams, polyurethane foams, alginate gels, 
hydrogels, hydrofibers, dextranomers, paraffin gauze, non-adherent, hyaluronic acid-
impregnated, silver coated, activated charcoal and protease-modulating matrix 
(Promogran) showed that there were no difference in efficacy among foam dressing, 
paraffin gauze dressing, polyethane film or polyurethane film when using split-thickness 
skin grafts. Time to complete healing was lower with foam dressing than silver coated 
dressing. For hydrofiber dressing time was lower than for paraffin gauze. There were no 
difference in complete healing rates between hydrofiber dressing and wet-to-dry gauze 
for surgical wounds. Hyaluronic acid impregnated dressings induced slower healing 
when compared to glycerin-impregnated dressing. The foam dressings were more 
effective than silver coated dressing when evaluating the complete healing of acute 
wounds. Hydrofiber dressings were more effective than paraffin gauzes. Alginate and 
paraffin dressing was compared in regard to pain as outcome. Alginate was found to be 
the superior (Chaby et al., 2007). 
Growth factors can be incorporated into hydrogels for controlled delivery when wound 
healing is the focus. Vascular endothelial growth factor (VEGF) has been reviewed for 
use in wound healing. VEGF stimulates wound healing by angiogenic cascade 
(angiogenesis: the formation of new blood vessels). Matrix mettaloproteinases (MMP’s) 
are enzymes that active when tissue in wounds is broken down for wound healing. VEGF 
increases endothelial cell secretion of interstitial collagenase, MMP1 (matrix 
metalloproteinase) and MMP2 (gelantinase A). VEGF stimulates an expression of MMP-
1, MMP-3 and MMP-9 in vascular smooth muscle cells to promote degradation of 
collagen. In general, VEGF provides endothelial movement in the extracellular space. 
Migration is induced by vasodilation and chemotaxis. Chemotaxis is movement of a cell 
as a response to a chemical gradient. Proliferation is stimulated partially by VEGF’s 
ability to lengthen the lifespan to endothelial cells. Wound healing is dependent on 
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forming of granulation tissue. VEGF is stimulating angiogenesis and thereby giving 
increased blood flow with nutrients to the wound (Bao et al., 2009). 
 
 
2.3. Hydrogels in wound therapy 
Hydrogels are water-swollen polymeric materials that maintain a distinct three-
dimensional structure. As dosage form, they are not greasy or oily and are water-
washable. They are considered to be nontoxic and can function as a vehicle for drugs in 
various forms (Kopecek, 2009). Due to their high water content, hydrogels possess 
excellent biocompatibility. There is a wide variety of design options for the preparation 
of hydrogels of different structures and properties. The usual classification relies on the 
origin of gelling material (Kopecek and Yang, 2007). 
Yang et al., (2008) proved that chitosan hydrogels are effective against E. coli when 
compared to control or other hydrogels. 
 
2.3.1. Hydrogels of natural origin 
Chitosan has been utilized for many medical and pharmaceutical preparations. Properties 
such as being biocompatible, non-toxic and soluble in weak acids make it an excellent 
wound dressing. It is positively charged, is strong tissue adhesive and forms gel easily. It 
has proven to enhance function of leukocytes, macrophages and fibroblasts to enhance 
granulation and rebuilding tissue (Huang and Fu, 2010). 
Hydrogels form stabilizing linkages between polymer chains. Covalent, hydrogen, ionic 
and van der Waals bonding link water and polymer strains to a gel (Bhatterai et al., 
2010). Polymer-polymer crosslinking between hyaluronic acid and chitosan has been 




Collagen is a biocompatible scaffold. Cells utilize collagen as a major component in the 
ECM (extracellular matrix). Collagen can be used to rebuild skin after wounding. 
Collagen has been used in tissue engineering and in delivery systems. Collagen can be 
combined with other materials for tissue regeneration. Growth factors have been 
incorporated into collagen to enhance healing. Biocompatibility and low antigenicity 
make collagen a good natural polymer. Its weak feature is mechanical weakness. 
Collagen can be extracted from animal tissue. Human collagen can be made as a 
replacement for animal origin collagen that can be potentially harmful because of 
microbial contamination (Huang and Fu, 2010). 
 
Galantine is widely used in pharmaceutical industry because of biodegradability and 
biocompatibility. Gelatine is normally denatured and has a low antigenicity. Isoelectric 
point can be altered to make galantine suitable for a wide array of uses with different 
charges and pH. Growth factors have been incorporated into galantine vehicles and used 
as controlled release systems for tissue like skin in wound regeneration. Galantine 
expresses structural differences that can be utilized to fit a fair selection of medical uses. 
Galantine can also be used as a vehicle for cells for skin regeneration (Huang and Fu, 
2010). 
 
Fibrin and fibronectin are components in the ECM with many roles. They induce 
attachments of cells. Fibrinogen can be isolated from plasma of patients. Fibrin is a 
network of polymerized fibrinogen. Thrombin is an enzyme that polymerizes fibrin and 
acts as ECM fibrin glue. Fibrin is biocompatible and has high tissue like water content. 
Fibrin’s mechanical properties are somewhat like soft tissue. Fibrin has the ability to be 
injected as a liquid in vivo and forms to a gel in situ. Fibrin can also be used as a cover to 
stop bleeding and skin graft fixation. Fibrin undergoes rapid degradation in vivo and 
formulations will have stability problems (Huang and Fu, 2010). 
 
Alginate is obtained from brown algae and has a long history in drug delivery and tissue 
engineering. Alginate is almost non-toxic, biocompatible, with non-immunogenicity, low 
17  
cost and simple gelation procedure. It is used as a wound dressing, vehicle for proteins 
and growth factors, and liposomes (Huang and Fu, 2010). 
 
 
2.3.2. Hydrogels of synthetic origin 
Carbopol polymers have the ability to thicken, suspend and stabilize aquatic solutions. 
With more than forty years on the market, Carbopol is well tested and have many uses. 
Cosmetic formulations are among the most abundant. Carbopol has excellent 
characteristics as a vehicle for drug delivery (Islam et al., 2004; Desai et al., 2006) 
Carbopol gels are widely used because they are more stable and mechanically durable 
than natural hydrogels like chitosan. Biocompatibility of synthetic hydrogels is on the 
other hand not as good as for some hydrogels of natural origin, for example chitosan gels 
(Keong and Halim, 2009).  
 
2.3.3. Chitosan hydrogels 
Chitosan hydrogels have been widely studied as topical formulations. Among others, 
Alsarra (2009) evaluated chitosan hydrogels in topical formulations for burn wounds. 
Different molecular weight and different degree of deacetylation ranges were compared. 
Chitosan formulations were compared also with fucidin ointment and placebo 
formulation for treatment of rats. Although high molecular weight (HMW) chitosans will 
be more viscous than low molecular weight (LMW) one and the medium molecular 
weight (MMW) at the same concentration, Alsarra proved that HMW chitosan was more 
effective than fucidin ointment when measuring wound contraction over time. Fucidin 
gave approximately the same results as MMW chitosan. The treatment with HMW 
chitosan gave no visible scarring after 12 days, and treatment with fucidin gave visible 
scarring. In conclusion, all formulations with chitosan gave better wound healing results 
than the placebo (Alsarra, 2009). 
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Ribeiro et al. (2009) also studied chitosan hydrogels in wound healing. They found that 
chitosan was able to promote adhesion and proliferation in wounds. Chitosan was not 
found to be cytotoxic in this study. Burn wounds of 3rd degree were treated with chitosan 
hydrogel and phosphate buffered saline, respectively The healing was measured through 
histological studies and evaluation of wound size. Chitosan gave better results than the 
control. 
Murakami et al. (2010) studied wound healing in healing-impaired wounds. After 
inducing controlled wounds in rats, they used mitomycin C that inhibits cell proliferation 
in fibroblasts, keratinocytes and endothelium in the wound. They found that the blend of 
chitin/chitosan and fucoidan powders showed better wound healing capabilities than 
alcium alginate dressing and control. c
 
2.3.4. Liposomal hydrogels 
2.3.4.1. Liposomes as topical drug delivery systems 
Liposomes have a promising future in drug transport and delivery. They can be prepared 
from natural or synthetic origin lipids (Škalko et al., 1998). According to the method of 
preparation, liposomes may vary in their size and lamellarity. They can be characterized 
as small unilammelar vesicles (SUVs; 25-50 nm in diameter), large unilamellar vesicles 
(LUVs; 50-500 nm) or large multilamellar vesicles (LMVs; 500-10000 nm) (New, 1990).  
 
FIGURE 7: LIPOSOMAL STRUCTURE (HTTP://WWW.BRITANNICA.COM) 
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The size of liposomes will affect the entrapment efficiency for both lipophilic drugs, 
which will accommodate themselves in lipid bilayers of the vesicle and hydrophilic 
drugs, which will be entrapped in the liposomal core. Phosphatidylcholine made 
liposomes can be stabilized with cholesterol. Span 80 and Tween 80 are surfactants that 
can enhance permeation through the stratum corneum and epidermis when combined 
with liposomes. Regarding the topical application, large liposomes will not readily 
penetrate the stratum corneum (Cevc, 2004). 
  
Liposomes can penetrate the skin by three mechanismes: Lateral diffusion, trans-
epidermal osmotic gradient or pilosebaceous units. Lateral diffusion is lipid exchange 
between membranes. Phospholipids with less than 16 carbons exchange membranes in 
minutes to hours and with long-chain require hours to days. Trans-epidermal osmotic 
gradient is a hydration force that sucks liposomes into the epidermis (El Maghraby et al., 
2008;de Leeuw et al., 2009). 
Liposomes have a tendency to accumulate in the skin. That can be preferable when 
topical administration is desired as in wound healing. When transdermal delivery is the 
goal, various types of vesicles can be prepared such as niosomes, vesicles with non-ionic 
surfactants. The liposomes express enhanced penetration ability and elastic properties. 
Ethosomes are vesicles containing ethanol. Ethanol enhances skin penetration and can be 
used to deliver drugs deeper to the skin. Transfersomes are even more elastic and 
deformable. Transfersomes can move through channels one tenth of their diameter 
(Benson, 2009). 
Liposomal delivery systems have been widely studied in topical administration and there 
are dozens of marketed cosmetic and pharmaceutical products on the market or in clinical 
trials right now (Benson, 2005). Several clinical trials confirmed the applicability of 
lipsomes in the treatment of skin diseases, such as clinical trial proving that liposomes 
with clindamycin were superior to lotions containing the same drug in non-vesicle form 
(Škalko et al., 1992).  
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2.3.4.2. Liposome-based chitosan hydrogels 
Liposomal chitosan gel formulations were of particular interest when preparing 
formulation in this study. Hydrogels as vehicles for liposomal dispersions are well 
established and studied for various routes of drug administration. Hydrogels preserve the 
original structure of liposomes and make the preparations more user friendly, resulting in 
better patient acceptability and compliance (Pavelić et al., 2001). It is especially 
important for topical administration where the retention of the formulation at the 
administration side affects the efficiency of the therapy, such as with hydrogels as 
vehicles for liposomes with metronidazole for treatment of Rosacea (Škalko et al., 1998). 
Mourtas et al. (2008) studied the rheological properties of hydrogels prepared with 
liposomes. The mixtures of Carbopol 974 and hydroxyethylcellulose were made with 
glycerine, citrate buffer and preservatives. Liposomes made of phosphatidylcholine (PC) 
and hydrogenated phosphatidylcholine (HPC) were used, varying in the degree of 
lamellarity of the membranes. Although Mourtas et al. (2008) used quite low 
concentrations of liposomes in their gels, they found that liposomal composition has the 
potential to alter hydrogel viscosity. The hydrogenated liposomes showed to have a 
higher transition state (50 °C) than the non-hydrogenated liposomes. PC was at a liquid 
state under test conditions, whereas HPC was not. This can explain why HPC can alter 
viscosity to a higher extent than PC. Size and lamellar types of liposomes showed 
approximately the same rheological effects on the gels (Mourtas et al., 2008). 
Gabrijeličič and Šentjurc (1994) studied liposome stability and liposome transport from 
hydrogels into pig skin. They found that hydrogels of carboxymethylcellulose and 
xanthan did not hinder soya lecithin-cholesterol liposomes transport to the skin. 
Hydrophilic polymers can change the stability to liposomes, like xanthan polymers 
(Gabrijeličič and Šentjurc, 1994). 
Pavelić et al. (2001) prepared liposomes by the polyol dilution and proliposome methods. 
They proved that hydrogels prepared from carbopol polymers increase the stability and 
enhance the release time of the liposomally entrapped drugs. Liposome-based hydrogels 
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were evaluated in the simulated vaginal conditions and the findings confirmed that 




.4. Chloramphenicol as model drug  
Chloramphenicol is an antibiotic drug mostly used for bacterial conjunctivities. 
Chloramphenicol has a broad spectrum of activity against both Gram positive and Gram 
negative bacteria, rickettsias and Chlamydia. The specific effect is inhibition of protein 
synthesis in microorganisms. Chloramphenicol has effect on a wide array of bacteria, 
among them, one present in wounds as well (Helms et al., 2006). 
Although the applicability of chloramphenicol in the treatment of wounds remain to be 
confirmed through broader clinical evaluation, preliminary results by Heal et al. (2009) 
indicate that single administration of chloramphenicol ointment to suturated wounds after 




FIGURE 8: STRUCTURE OF CHLORAMPHENICOL 
We have selected chloramphenicol as a model antibacterial drug. Moreover, the 
formulation choice for chloramphenicol topical dosage forms is limited by its solubility 
and represents pharmaceutical challenge. 
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3. Aims of the study 
 
The main objective of the project was the development of topical formulation to be 
applied in treatment of skin wounds, namely burns. Hydrogels are one of the most 
popular types of wound dressings, and hydrogels of natural origin are known to have 
several advantages over synthetic origin hydrogels. Chitosan based hydrogels were 
selected as delivery system for wound treatment. Chloramphenicol was used a model 
antibacterial agents for the prevention or treatment of wound infections. 
More specific aims were: 
• Optimize chitosan hydrogels in regard to the effects of polymer concentration, 
type of chitosan used (low versus high molecular weight) and additives, on the 
texture properties of formed gels 
• Incorporate liposomes carrying chloramphenicol in hydrogel and evaluate the 
effect of incorporated liposomes on hydrogel properties.  
• In parallel, develop a rapid and reproducible method to analyze gel properties and 
compare batch-to-batch variations and stability. 
• Test the stability of hydrogels and liposome-based hydrogels in accelerated 
stability conditions 











4. Materials and Methods 
 
4.1.1. Materials 
Acetic acid (glacial) GR for analysis, Merck, Darmstadt, Germany (K25892763 846 
1.00063.1000) 
Acetonitrile, isocratic grade for liquid chromatography, Merck, Darmstadt, Germany 
(I483791 918, 1.14291.2500) 
Alginic acid, sodium salt, (Brookfield viscosity 20000-40000 cps) Sigma-Aldrich 
Chemistry, St Luis, USA (61496MJ/MKBB8171, 180947-100G) 
Carbopol Ultrez® 10 NF, Noveon, Cleveland, USA (LOT #: CC73RZG554) 
Chitosan, low molecular weight, (Brookfield viscosity 20000 cps) Sigma-Aldrich 
Chemistry, St Luis, USA (61496MJ/MKBB4232, 448869-250G/448869-50G) 
Chitosan, medium molecular weight, (Brookfield viscosity 200000 cps) Sigma-Aldrich 
Chemistry, St Luis, USA (MKBC0060, 448877-250G) 
Chitosan, high molecular weight, (Brookfield viscosity 800000 cps) Sigma-Aldrich 
Chemistry, St Luis, USA (MKBB0585 419419-250G/448869-50G)  
Chloramphenicol micronisated MBK, Norsk Medisinal Depot, Oslo Norway (30 50 94, 
Anr 2N005/2) 
Chloroform (HPLC grade) Merck, Darmstadt, Germany, (K38551444 812 1.02444.1000) 
Distilled water  
Glycerine, anhydrous pure, Merck Darmstadt, Germany, (K29746193 142, 
1.04093.1000) 
Lipoid S 100 (soybean lecithin with 100% phosphatidylcholine), generous gift from 
Lipoid GMBH, Ludwigshafen, Germany (790611-03/911) 
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Methanol (HPLC grade) Merck Darmstadt, Germany (I515007 950, 1.06007.2500) 
Polyamide membrane, Sartorius AG, Göttingen, Germany 
Triethylamine (for synthesis) Merck, Darmstadt, Germany (S3801652, 8.08352.1000) 
Triglycerides (middle chain) Fagron GmbHEtCo.KG, Barsbüttel, Germany 
 
4.1.2. Instruments 
Agilent technologies UV/Visible spectrophotometer, G1103A (Santa Clara, CA/USA). 
Beckmann L8-70M Ultracentrifuge, Beckmann Instruments Inc, Palo Alto, USA 
Biofuge Stratos, Heraeus instruments, Dipl.Ing Holm AS, Oslo Norway 
MS2 Minishaker, Chiron AS, Trondheim Norway 
Branson 5510E-MT, Bransonic ultrasonic cleaner, Danbury USA 
Büchi Waterbath B480, Büchi Vac V-500, Büchi vacuum controller B-721, Büchi 
rotavapor R-124, Büchi labortechnik, Flawil Schwitzerland 
Distillation unit Distinction D4000, Bibby Sterlin LTD. Staffordshire UK 
“Freiburger schlange schnecke”: Ismatec IPC, Dan Maszansky AS, Laboratorieutstyr, 
Oslo Norway 
TA.XT.Plus Texture Analyser, Stable Microsystems, Surrey UK Backward Extrusion Rig 
A/BE, Stable Microsystems, Surrey UK 
Waters 2695, Separations Module, Waters 2487 Dual λ Absorbance Detector, Waters, 
Milford USA; with XTerraTM RP18 5μm (3.9*150 mm) W01671T 004 column from 




4.1.3. Computer programs 
Texture analyser: Millennium 32 Chromatography Manager (4.0) 
HPLC: Texture Exponent, 32 (3.0.5.0) Stable Microsystems, Surrey UK 
 
 
4.2. Preparation of hydrogels 
4.2.1. Preparation of carbopol hydrogels 
Carbopol Ultrez® forms gels easily and quite rapidly. Distilled water (DW) and Carbopol 
Ultrez® (CU) were gently mixed in the ratios from 99:1 – 99.8-0.2 (w/w). Appropriate 
amount of triethylamine was added under gentle stirring to reach a pH of 6 (measured 
with indicator paper). In the cases when air bubbles were observed, bath sonication for up 
to 30 minutes was applied. The hydrogel was allowed to swell for 24 hours at room 
temperature. 
 
4.2.2. Preparation of chitosan hydrogels 
Chitosan forms gels when dispersed in a weak acid. Low (LMWC), medium (MMWC) or 
high (HMWC) molecular weight chitosans were dispersed in 2.5 % acetic acid solution. 
Alternatively, 0.25, 1, 1.5, 2 and 4% acetic acid solutions were used when appropriate. 
The concentration of chitosan in the acetic acid was in the range of 1-6% (w/w). The 
mixture was stirred manually for 10 minutes and sonicated for 30 minutes. Chitosan 
hydrogels were initially allowed to swell in a refrigerator to keep the gels stable, but the 
time necessary for gel formation was long, therefore in optimized procedure the hydrogel 
was allowed to swell for 48 hours in a sealed container at room temperature. The choice 
of acid and preparation protocol was based on Alasarra (2009) and Cao et al. (2009). 
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Attention was given to the stirring conditions as it was found that the use of magnetic 
stirrer in a steel bowl trapped more air, similar to when the mixing was performed in 
mortar.  
 
4.2.3. Determination of the effect of additives on gel properties 
Glycerine (1, 2 and 9% (w/w), respectively) was mixed with acetic acid before adding the 
chitosan in predetermined amount. Glycerine content of 1 % (w/w) was preferred since it 
did not alter the original gel viscosity but increased the stability.  
In preliminary testing of the effect of sodium alginate on gel properties, the addition of 
2% (w/w) alginate resulted in too low viscosity of the gel, and was not further evaluated. 
 
 
4.3. Texture analysis 
Texture analyser can be applied in evaluation of formulation properties of hydrogles. The 
instrument provides options to measure backward extrusion, forward extrusion and 
multiple extrusions. The recorded forces represent responses to tension, compression, 
penetration or bending. The selected probe will move at a programmed speed and until 
specified force, distance or strain is reached, which will be indicated in the record. 
For measuring the backward extrusion force on chitosan gels, at first the A/BE-d35 probe 
with back extrusion rig and 35 mm disc and a torus weight was applied. As chitosan gels 
are sticky and dehydrate at the walls of the container, a submerged probe was found to be 
more suitable. The submerged disc proved to better resulting in with variations in the 
readings. 
Force and height were calibrated at the start of each measurement. Fifty grams of gel 
were used in all measurements. The disc was moved 1 mm from the bottom of gel and 
rested for 30 seconds to relieve air-bobbles under the disc. The probe was then moved to 
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15 mm (submerged) and rested for 15 seconds (Figure 9). Five measurements were run 
with 15 seconds rest between every run. Two sets of conditions for testing were found to 
be equally good, namely 
1: Pre-test speed: 1 mm/sec; test speed: 1 mm/sec; post-test speed: 1 mm/s; distance 10 
mm; return to the start point  
2: Pre-test speed: 4 mm/sec; test speed: 4mm/sec; post-test speed: 4 mm/s; distance 10 




FIGURE 9: MEASUREMENT SET UP TEXTURE ANALYSER 
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A    B 
FIGURE 10: MEASURING POSITION WITH PROBES  
A: Cylinder probe B: Disk probe (35 mm in diameter) 
Starting point for the cylinder probe was above the gel. Starting point for the 35 mm disc 
was submerged as see in the Figure 10B. 




4.4. Liposomal hydrogels 
4.4.1. Empty liposomes 
Lipoid S100 (200 mg) was dissolved in methanol in the ratio 1:10 (w/v). Methanol was 
allowed to evaporate in a rotavapor for at least 2 hours at 100 mmHg at 30 °C and 60 
rpm, and then 30 minutes at 45 mmHg at 30 °C and 60 rpm. The dry phospholipid film 
was re-suspended by the addition of 10 ml of distilled water. Vortex was used to help to 
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dislocate the film when needed. Liposomes were refrigerated for at least 24 hours before 
further characterization.  
 
4.4.2. Liposomes with chloramphenicol  
Chloramphenicol (20 mg) was dissolved together with Lipoid S100 (200 mg) in excess 
methanol and the solvent evaporated under the same conditions as described for empty 
liposomes. Liposomes were refrigerated for at least 24 hours before further 
characterization.  
 
4.4.3. Entrapment efficiency determination 
In order to separate liposomally entrapped chloramphenicol form unetrapped 
chloramphenicol, ultracentrifugation was applied. Liposomes were centrifuged in 
Beckman-L8-70M ultracentrifuge (Brea, CA/USA) at 10 °C, for 25 min period at 32000 
rpm. Upon centrifugation, the pellet was resuspended in 1500 μl distillated water, and an 
aliquot (10 μL) further diluted and used in spectrophotometrical and HPLC analyses. An 
aliquot (30 μL) of the supernatant was also further diluted with methanol and the 
chorlamphenicol content determined both spectrophotometrically and by the HPLC 
analysis.  
Spectrophotometrical analysis: A stock solution of chloramphenicol was made by 
dissolving 51.7 g of chloramphenicol in 200 mL of methanol. Working solutions were 
prepared by diluting the stock solution to desired concentration with methanol and 
calibration curve prepared using Agilent technologies UV/Visible spectrophotometer, 
G1103A (Santa Carla, CA/USA) at 268 nm wavelength.  
HPLC analysis: HPLC system consisted of a Water separation module 2695 and Waters 
2487 UV-spectrophotometer detector. Column used was a XTerraTM RP18 5μm (3.9*150 
mm) W01671T 004 column from Waters S.A.S. (Massachusetts, USA). The mobile 
phase consisted of 45% methanol, 55% filtered H2O and 0,1% acetic acid (glacial). The 
temperature of column was maintained at 35◦C±5◦C and the temperature of samples was 
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maintained at 35◦C±2◦C during the chromatographic separation. The flow rate was 1 
ml/min and running time for each sample was 5 min monitored at UV 270 nm.  
 
4.4.4. Particle size analysis 
Dynamic light scattering (DLS) on the NicompTM model 380 particle sizing system with 
software version C-370 V-1.51a, and equipped with a fixed 90o external fiber angle and a 
632.8 nm, 5 mW He–Ne laser was used to determine average particle size and size 
distribution of prepared liposomes. In order to avoid any contamination with dust, sample 
preparation was carried out in a clean area using particle-free equipment: all handling 
was done in a laminar air-flow bench, test tubes were submersed in particle-free water 
and sonicated for 15 min in an ultrasonic bath and rinsed with freshly filtered (0.2 nm 
pore size syringe filter) water prior to use. The vesicle-dispersion was diluted empirically 
with freshly filtrated medium until an intensity of 250–350 kHz was achieved (Hupfeld et 
al., 2006). 
 
4.4.5. Preparation of chitosan gels with liposomes 
Liposomal preparations (empty liposomes or liposomes containing chloramphenocol) 
were incorporated in prepared chitosan hydrogels (concentration varying from 1 to 6%, 
w/w) by hand stirring (Skalko et al., 1998) and allowed to stabilize for 2 hours. The final 




4.5. Stability testing 
4.5.1. Chitosan gels and liposomal chitosan gels in accelerated stability testing  
Accelerated stability testing was applied to evaluate the stability of prepared hydrogels. 
The gels (50 g) were examined by the help of texture analyser (method 4.3) before and 
after one month of storage in an airtight container at 40 °C (thermostat).  
TABLE 2: ACCELERATED STABILITY TESTING 
Chitosan type (concentration; % w/w) Liposomal concentration (w/w, 
liposomal suspension per total) 
Low molecular weight (6%) 0%
Low molecular weight (6%) 1%
Low molecular weight (6%) 5%
Low molecular weight (6%) 10%
Low molecular weight (6%) 15%
Medium molecular weight (3.5%) 0%
Medium molecular weight (3.5%) 1%
Medium molecular weight (3.5%) 5%
Medium molecular weight (3.5%) 10%
Medium molecular weight (3.5%) 15%
High molecular weight (2.5%) 0%
High molecular weight (2.5%) 1%
High molecular weight (2.5%) 5%
High molecular weight (2.5%) 10%
High molecular weight (2.5%) 15%
 
 
4.5.2. Accelerated stability test of liposomal HMWC gels containing glycerine 
Liposomal chitosan gels containing 1% glycerine, were stored for one month period in an 
airtight container at 40°C. The properties of gels were measured before and after on 










liposomal suspension per total)
Glycerine 
(w/w) 
High molecular weight (2.5%)  0% 1%
High molecular weight (2.5%) 1% 1%
High molecular weight (2.5%) 5% 1%
High molecular weight (2.%) 10% 1%
 
 
4.5.3. Stability testing under freezing conditions 
HMWC gels, HMWC liposomal gels, with and without glycerine were evaluated on 
texture analyser before and after storage at -22 °C for 48 hours. The frozen gels were 
allowed to thaw at room temperature prior to the measurement. 
 
TABLE 4: STABILITY TESTING UNDER FREEZING CONDITIONS 
Chitosan (concentration; 
w/w) 
Liposomal concentration (w/w, 
liposomal suspension per total) 
Glycerine (w/w) 
High molecular weight (2.5%)  0% 0% 
High molecular weight (2.5%) 1% 0% 
High molecular weight (2.5%) 5% 0% 
High molecular weight (2.5%) 10% 0% 
High molecular weight (2.5%)  0% 1% 
High molecular weight (2.5%) 1% 1% 
High molecular weight (2.5%) 5% 1% 
High molecular weight (2.5%) 10% 1% 
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4.6. In vitro release rate 
4.6.1. Release from spiral system and collection of samples 
Twenty five grams of HMWC (2.5%, w/w) hydrogel with liposomes (10%, w/w) 
containing chloramphenicol (both entrapped and unentrapped) were applied to the spiral 
in vitro model (Figure 10). The in vitro release model is also called “Freiburger 
schlange  schnecke”.  The acceptor consisted of 50 ml of medium chain triglycerides 
(MCT) and was pumped through the spiral (100 rpm). A polyamide membrane separated 
the acceptor phase (MCT) from the gel in the spiral.  
 
FIGURE 11: THE IN VITRO RELEASE SET UP 
One ml samples were taken from the flow medium after 5, 10, 15, 25, 35, 45, 60, 75, 90, 
180 and 300 min. The concentration of chloramphenicol in each sample was determined 





5. Results and discussion 
5.1. Texture analysis 
5.1.1. Optimisation of measurement conditions 
Although texture analyser is widely used in pharmaceutical and cosmetic industry to 
evaluate gels and gel like structures, the scientific literature on the use of texture analysis 
for that purpose is rather limited. At the beginning of the optimization of the 
measurements, we used two types of hydrogels, namely Carbopol Ultrez and chitosan 
hydrogels to exclude the effect of the type of gel on the method set up. Carbopol Ultrez 
based gels are stiff but can be characterized as visco-elastic systems with pseudo plastic 
and shear thinning behaviour (Fresno-Contreras et al., 2001). Non-Newtonian fluids have 
typical shear thinning behaviour. Hydrogels that are pseudo plastic would be suitable to 
be characterized by the texture analysis because of lower mechanical stress in the 
characterization process than in the methods with more kinetic energy put on the gels.  
 
FIGURE 12: REPRESENTATIVE EXAMPLE OF MEASUREMENT READING FOR CARBOPOL GEL 
The four factors are recorded: Force 1, Area 1, Force 2, and Area 2. Standard deviations 
from 5 separate readings were all below 2%. The probe used was cylinder type. 
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By comparing the maximum force, the minimum force, and area under the curve for 
downward forces on the probe and area for the retraction forces (Figure 12), the insight 
on the texture properties of the gel can be obtained. Initially the readings were found to 
vary within 5-10%. We observed that the different beakers used in the measurement, 
varying the placement for the beaker and the surface of the gel (smoothness) had the 
direct effect on measurements. Therefore, it was important to fix the beaker to a rack and 
mark the placement position. Under these more controllable conditions, characterization 
of Carbopol hydrogels gave reproducible results with standard deviations below 2 %.  
Chitosan hydrogels on the other hand were not giving the same measurement 
reproducibility under the same measurement conditions. Chitosan gels were more fluid 
like, almost consistence of honey. As a result, the gel started to flow when put under 






FIGURE 13: TYPICAL READING FOR LOW MOLECULAR WEIGHT CHITOSAN  
LMWC gel (5%, w/w) Speed: 1 mm/sec, distance 10 mm, 35 mm cylinder probe.  
 
Another important finding was related to the loss of incorporated water. Water evaporates 
readily from the gel when left in the air. So when thin layers of gel are left on the beaker 
walls, it dries out in minutes and sticks to the walls. This adherence interferes with 
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characterization. A thin film will change the surface adherence of the probe and interfere 
with the results. As seen in Figure 13, forces recorded increased with every run. The left 
graph (A) shows what happened when the probe was used for repeated runs without any 
washing or drying during the process. The right graph (B) shows what happened when 
the probe was washed, but the beaker was not washed or dried during the measurement. 
 
Results improved with thorough washing during the measurement, but the measurement 
become very time-consuming. Even when the beaker was dried with a tissue paper, and 




FIGURE 14: TYPICAL READING FOR LOW MOLECULAR WEIGHT CHITOSAN 
LMWC gel (5%, w/w), Speed: 1 mm/sec, distance 10 mm, 35 mm cylinder probe. The 
probe was washed and beaker dried between the runs. 
 
In order to further evaluate the effect of water loss on the gel characterization, chitosan 
gels were put in a thermostat (40 °C) to study the changes in the gel. When left 
uncovered, water evaporated gradually and the gel turned into more rubber-like form. 
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Figures 15 and 16 show the same chitosan hydrogel (the same concentration) after one 
and two weeks in the oven. The adherence-factor with the gel sticking to the walls also 
increased. The force needed to compress the gel was approximately 5 times more as 
compared to freshly prepared gel. By comparison, chitosan gels left airtight in the oven 
became gradually more fluid-like. 
 
FIGURE 15: TYPICAL READING FOR LOW MOLECULAR WEIGHT CHITOSAN  
LMWC gel (5%, w/w) stored uncovered at 40 °C for one week. Speed: 1 mm/sec, 
distance 10 mm, 35 mm cylinder probe.  
 
When the gel was left for 2 weeks in the oven, the force needed to compress the gel was 
over 4000 g, approximately 25-30 times the force needed before it was put in the oven. 
Chitosan gels become more rubber-like when water vaporizes. 
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FIGURE 16: TYPICAL READING FOR LOW MOLECULAR WEIGHT CHITOSAN  
LMWC gel (5%, w/w) stored uncovered at 40 °C for two weeks. Speed: 1 mm/sec, 
distance 10 mm, 35 mm cylinder probe. 
If the chitosan gel was left even longer in the oven, the polymer can transform and obtain 
plastic properties. Figure 17 shows dried out chitosan. The machine stopped at 55 kg 
force. 
 
FIGURE 17: TYPICAL READING FOR LOW MOLECULAR WEIGHT CHITOSAN UPON DRYING OUT 
LMWC gel (6%, w/w) stored uncovered at 40 °C until drying out. Speed: 1 mm/sec, 
distance 10 mm, 35 mm cylinder probe. 
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The same concentration of chitosan (LMWC; 5% w/w) was also exposed to air. Although 
the results are not statistically significant, they can be used as an indication that the 
exposure to air can increase cohesiveness of the gel (Figure 18 and Figure 19). 
 
 
FIGURE 18: THE EFFECTS OF EXPOSURE TO AIR ON TEXTURE CHARACTERISTICS 
LMWC (5%, w/w) were exposed to air for 0, 0.5 and 2 hours. Speed: 1 mm/sec, distance 
10 mm, 35 mm cylinder probe. 
The results with the largest forces (absolute values) represent gels exposed for two hours, 
the middle forces gels exposed for 0.5 hours, and the lowest forces were not exposed to 
air more than during preparation of gel (Figure 18). 
 
Chitosan formulations are fluid at low concentrations and get thick and firm when 
prepared at concentrations close to maximum soluble amount. Considering that the gels 
were destined to be applied onto skin, we focused on the spreadability of gels as well. 
The personal evaluation and testing revealed that preferable concentration of chitosan gel 
for LMWC would be around 6%, MMWC 3.5% and HMWC 2.5% (w/w).  
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Different concentrations of acetic acid were used for gel preparation during the process of 
gel optimization. Addition of acetic acid in concentration of 2.5% (w/w) provided the gel 
pH value of approximately 4.5 (Figure 19). Any lower pH would not be suitable for skin 
formulations. Yang et al. (2009) showed that swelling of chitosan is best at pH right 
below 4 and is decreasing when gels are approaching neutral conditions. Yang et al. 
(2009) also propose that washing of the prepared gel can neutralize the gel. 
 
 
FIGURE 19: LMWC (FROM LEFT TO RIGHT: 2.5-7%, W/W) CONTAINING 2.5% (W/W) ACETIC ACID 
 
 
FIGURE 20: TYPICAL READING FOR LMWC (6%, W/W) GEL WITH 2.5% (W/W) ACETIC ACID  
The sample was measured with back-extrusion equipment and 40 mm disc. Speed: 1 
mm/sec, distance: 15 mm. The beaker was moved between every run. 
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At this stage of method development, the reproducibility of measuring was improving. 
Back-extrusion disc with special beaker was placed in a mounted track. The disc was 
submerged into the gel. This minimized adherence to the walls and decreased the elapsed 
time for testing. Initially 40 mm disc was used. Even if the track for the beaker was 
controlling the placement, there was some slack. This slack is detectable as seen in Figure 
21. The solution was to use 35 mm disc instead. With the smaller disc, decreased force 1 
and force 2 was inevitable.  






FIGURE 21: THE EFFECT OF GEL CONCENTRATION ON TEXTURE MEASUREMENT 
LMWC gel (4%; w/w) containing 2.5% (w/w) acetic acid (A) and LMWC gel (5%, w/w) 
containing 2.5% (w/w) acetic acid (B) were measured. Speed: 1 mm/sec, distance: 15 mm 
and 40 mm disc (back extrusion). 
 
The next step in development of texture analysis method to be used in characterization of 
chitosan gels was to determine the optimal speed and distance the probe should travel 
into the gel. The method should be carried out as fast as possible without jeopardizing the 
accuracy and variation. The method should also be applicable to various kinds of chitosan 




FIGURE 22: THE EFFECT OF DIFFERENT FORCES AND DIFFERENT PROBE SPEEDS ON 
MEASUREMENTS  
The gel used was LMWC gel (6%; w/w) containing 2.5% (w/w) acetic acid and 5% 
liposomal dispersion (w/w of total). Measured with back-extrusion equipment and 35 mm 
disc. Distance: 10 mm. Speed: Black: 0.5 mm/sec, green: 1 mm/sec, blue: 2 mm/sec and 
purple: 4 mm/sec. 
 
Different speeds yield different areas and forces. Faster probe speed gives increased 
force, but also decreased elapsed time. Total run time at 5 seconds and 20 seconds were 
found equally good, but 5 seconds was preferable because the measurement was faster. 
The initial method was using percentage of minimum force in the macro for calculating 
area. The new method for chitosan gels involved elapsed time instead. Method was now 
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found to be reproducible. Standard deviation was varying within less than 2%, and 
typically less than 1%.  
 
One precaution to be considered in regard to the newly established method was the fact 
that when the disc approaches the bottom, the force rises. This effect also increases with 
higher probe speeds. Disc further away from the surface gives a flatter curve response, 
especially with thicker (more viscous) gels. The working scope of the disc should be with 
good clearance to the gel surface and the bottom. The amount of gel used in measurement 
was found to be optimal if around 50-60 g was used. 
 
5.1.2. Established method (summary) 
 
 
FIGURE 23: TYPICAL MEASUREMENT PROFILE AFTER METHOD ESTABLISHMENT 
Comparison of 3+3 runs in two batches of LMWC gel (6%; w/w) with 2.5% (w/w) acetic 
acid and 10% liposomal dispersion (w/w per total) measured with Texture analyser, back-
extrusion equipment and 35 mm disc. Speed: 1 mm/sec, distance: 10 mm. 
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Figure 23 and Table 5 show two batches of LMWC gel (6%, w/w) with 10% (w/w) added 
liposomal dispersion. They seem quite similar at first glance (Figure 23). But p-values 
shown in Table 5 reveal that the two batches are statistically different when comparing 
force 1, area 1 or area 2 with p-values between 0.00003-0.0014. Force 2 has a p-value of 
0.241. P-values less than 0.05 indicate that there is less than 5% probability that the 
measured difference between the sample-sets are caused by coincidences. Even with 
small forces recorded, the method is capable of distinguishing between small variations 
within the tested gels. The method can maintain this reproducibility only when the same 
amount of gel is measured in each sample. Only then can the method differentiate 
between different structures and viscosity. The method can be used to examine 
differences between parameters involved in preparation methods and various raw 
materials (composition).  
TABLE 5: COMPARISON OF TWO BATCHES OF LIPOSOMAL LMWC GELS 
Batch 1/run  Fo )rce 1 (g   Area 1 (g·sec)  Fo g)rce 2 (   Area 2 (g·sec) 
1  25.074  175.286 17,802 140.111 

























Batch 2/run  Fo )rce 1 (g   Area 1 (g·sec)  Fo g)rce 2 (   Area 2 (g·sec) 





































Comparison of 3+3 runs in two batches of LMWC gel (6%, w/w) containing 2.5% (w/w) 
acetic acid and 10% liposomal dispersion (w/w of total) measured with back-extrusion 
equipment and 35 mm disc. Speed: 1 mm/sec, distance: 10 mm. The standard deviation 
(SD) from the 3 runs was calculated as well as the variation coefficient (VC). VC value 
represents the percentage of how much SD varies from the average values. P-values are 
calculated for comparison.  
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5.2. Stability testing 
5.2.1. Accelerated stability testing 
Low molecular weight chitosan hydrogels prior to testing 
TABLE 6: LMWC GELS PRIOR TO ACCELERATED STABILITY TESTING  
A: LMWC gel (6.0%, w/w) without liposomes 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 170.267 337.991 123.136 268.044 
SD 0.802 2.401 0.271 1.422 
VC 0.471 0.710 0.220 0.531 
B: LMWC gel (6.0%, w/w) with 1% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 165.903 332.501 119.966 260.935 
SD 0.483 2.138 0.715 1.192 
VC 0.291 0.643 0.596 0.457 
C: LMWC gel (6.0%; w/w) with 5% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 123.005 246.709 89.074 200.165 
SD 0.612 0.907 0.427 0.691 
VC 0.497 0.368 0.479 0.345 
D: LMWC gel (6.0%, w/w) with 10% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 96.996 202.006 75.243 165.778 
SD 0.646 0.910 0.359 0.610 
VC 0.666 0.451 0.478 0.368 
D: LMWC gel (6.0%, w/w) with 15% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 74.00 161.068 61.784 135.415 
SD 0.572 0.899 0.187 0.571 
VC 0.766 0.558 0.302 0.422 
The Table 6 shows maximum force (force 1), minimum force (force 2), area 1 and area 2. 
The values are the average (Ave) of 5 runs and are absolute. The standard deviation (SD) 
from the 5 runs is calculated as well as the variation coefficient (VC). Measured with 
back-extrusion equipment and 35 mm disc. Distance: 10 mm, speed: 4 mm/sec. 
All chitosan preparations were found to be less cohesive after one month storage in the 
oven (40 °C). MMWC gels were found to remain of similar viscous properties after one 
month storage at elevated temperature. However, the MMWC were also the most 
cohesive before the test started. The HMWC are expected to be more stable. However, 
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we need to mention that the degree of deacetylation was not considered when evaluating 
the stability in this study.   
As shown in Figure 24, the texture property of chitosan gels is highly dependent on the 
concentration of chitosan used and the dilution of original gel by incorporation of 













FIGURE 24: THE EFFECT OF THE ADDITION OF LIPOSOMAL DISPERSION TO LMWC GEL 
LMWC gel (6%, w/w) containing 2.5% (w/w) acetic acid and 0-15% liposomal 
dispersion (w/w of total). Measured with back-extrusion equipment and 35 mm disc. 
Distance: 10 mm, speed 4 mm/sec. A: No liposomes; B: 1% liposomes (w/total), C: 5% 
liposomes (w/total); D: 10% liposomes(w/total); E: 15% liposomes (w/total). 
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FIGURE 25: THE EFFECT OF LIPOSOMES ON THE AREA 2 VALUES 
Moreover, we could visually observe the effect of added liposomes on gel property. The 









FIGURE 26: THE CHANGE IN LMWC GEL APPEARANCE IN RELATION TO INCORPORATION OF 
LIPOSOMES.  
A: No liposomes; B: 1% liposomes (w/total), C: 5% liposomes (w/total) 
The LMWC gels have a more brownish colour than the MMWC and HMWC gels. With 
incorporated liposomes the gels get increasingly more clouded and lighter in colour.  
With the increase in liposomal concentration incorporated in hydrogels, the area 2 
decreases in an approximate linear manner. Table 7 and Figure 25 indicate that the ratio 
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between force 2 and area 2 is roughly half in comparison between 15% liposomal gel and 
gel without liposomes (empty). The ratio between area 1 and force 1 is less than half for 
15% liposomal gel versus empty gel. This can indicate that cohesive effect is more 
affected by liposomes than adhesive effect. The consequence of adding liposomes is the 
lowering of gel viscosity.  
 
Medium molecular weight chitosan hydrogels prior to testing 
TABLE 7: MMWC BEFORE ACCELERATED STABILITY TEST 
A: MMWC gel (3.5%, w/w) without liposomes 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 253.132 534.868 201.767 427.788 
SD 1.141 2.863 0.649 3.796 
VC 0.451 0.535 0.322 0.887 
B: MMWC gel (3.5%, w/w) with 1% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 256.149 531.208 197.490 426.571 
SD 1.303 1.589 0.488 2.730 
VC 0.509 0.299 0.247 0.640 
C: MMWC gel (3.5%, w/w) with 5% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 216.942 436.780 157.762 355.567 
SD 0.624 0.610 0.702 1.060 
VC 0.288 0.140 0.445 0.298 
D: MMWC gel (3.5%, w/w) with 10% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 166.963 337.789 127.041 276.850 
SD 0.701 0.417 0.521 0.638 
VC 0.420 0.123 0.410 0.230 
D: MMWC gel (3.5%, w/w) with 15% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 97.169 202.584 76.589 165.777 
SD 0.242 0.185 0.189 0.380 
VC 0.249 0.091 0.247 0.229 
  
The values are the average (Ave) of 5 runs and are absolute. Measured with back-
extrusion equipment and 35 mm disc. Distance: 10 mm, speed 4 mm/sec.  
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If LMWC and MMWC gels are compared, the values for empty gels are higher for 
MMWC. With 15% liposomes (w/total) added to the gel, the values are still higher but 
the ratio is smaller. The area 2 for empty LMWC gel is 62% of the area 2 for MMWC 
gel. But with 15% liposomes added to both types of gel, the area 2 for LMWC gel is 81% 
of area 2 for MMWC gel. This indicates that LMWC can withstand higher concentrations 
of liposome dispersion added. But then again it needs to be prepared at higher 













FIGURE 27: THE EFFECT OF THE ADDITION OF LIPOSOMAL DISPERSION TO MMWC GEL 
A: No liposomes; B: 1% (w/total) liposomes, C: 5% (w/total) liposomes; D: 10% 
(w/total) liposomes; E: 15% (w/total) liposomes. Measured with back-extrusion 
equipment and 35 mm disc. Distance: 10 mm, speed 4 mm/sec. 
50 
 
FIGURE 28: THE EFFECT OF INCORPORATED LIPOSOMES ON THE AREA 2 VALUES 
The equation y = -17,555x + 439.64 with R² = 0.99089 can be used to prove that the 









FIGURE 29: THE CHANGE IN MMWC GEL APPEARANCE IN RELATION TO INCORPORATION OF 
LIPOSOMES.  





High molecular weight chitosan hydrogels prior to testing 
Empty HMWC gel (2.5%, w/w) appears to be more viscous than empty LMWC gel (6%, 
w/w). When both gels contain 15% (w/w) liposomal dispersion the consistency appears 
to be the same. As HMWC gel can be prepared at lower concentrations than both LMWC 
and MMWC gels, its acceptance limit for incorporation of liposomes can be higher.  
 
TABLE 8: HMWC GELS BEFORE ACCELERATED STABILITY TESTING   
A: HMWC gel (2.5%, w/w) without liposomes 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 188.155 373.192 135.640 301.060 
SD 0.958 0.154 0.552 0.411 
VC 0.509 0.041 0.407 0.136 
B: HMWC gel (2.5%, w/w) with 1% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 181.643 363.914 132.775 295.666 
SD 1.411 0.973 0.174 0.294 
VC 0.777 0.267 0.131 0.099 
C: HMWC gel (2.5%, w/w) with 5% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 113.301 221.628 81.714 183.522 
SD 1.766 1.229 0.511 0.220 
VC 1.558 0.554 0.625 0.120 
D: HMWC gel (2.5%, w/w) with 15% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 76.437 161.893 62.478 133.320 
SD 0.653 0.451 0.053 0.388 
VC 0.854 0.278 0.085 0.291 
 
The table shows maximum force (force 1), minimum force (force 2), area 1 and area 2. 
The values are the average (Ave) of 5 runs and are absolute. Measured with back-















FIGURE 30: THE EFFECT OF THE ADDITION OF LIPOSOMAL DISPERSION TO HMWC GEL 
A: No liposomes; B: 1% (w/total) liposomes, C: 5% (w/total) liposomes; D: 15% 
(w/total) liposomes. Measured with back-extrusion equipment and 35 mm disc. Distance: 
10 mm, speed 4 mm/sec. 
53  
 










FIGURE 32: THE CHANGE IN HMWC GEL APPEARANCE IN RELATION TO INCORPORATION OF 
LIPOSOMES.  
A: No liposomes; B: 1% (w/total) liposomes; C: 5% (w/total) liposomes 
The HMWC gel is clear in appearance when empty, but got more clouded when 
liposomes were incorporated. With 5% (w/w) or higher liposomal dispersion 
concentrations, the HMWC gel appeared white and opaque. 
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Low molecular weight chitosan hydrogels after one month storage at 40 °C 
There are no literature data available (up to the best of our knowledge) on the stability of 
liposomal chitosan gels. Several research groups studied to chitosan coated liposomes 
and their stability.  
Wang et al. (2010) studied the stability of chitosan anchored liposomes (CALs) and 
chitosan coated liposomes (CCLs). They proved that plain liposomes, CALs and CCLs 
are stable for 30 days when stored at 4 °C. When stored for 30 days at 25 °C, the plain 
liposomes showed fusion of liposomal particles, while the CALs and CCLs showed no 
changes in the sizes. Both the sizes of CALs and CCLs increased after 30 days at 37 °C. 
This proved that chitosan coated liposomes can be stored at room temperature or at 4 °C 
for a month, but not necessarily at 40 °C.  
Hafner et al. (2009) studied melatonin-loaded lecetin/chitosan nanoparticles. They 
examined the changes of drug loading, size, polydispersity and zeta-potential over a two 
months period at 4 °C. They proved that the most stable preparations were the largest 












TABLE 9: LMWC GELS AFTER ACCELERATED STABILITY TEST 
A: LMWC gel (6.0%, w/w) without liposomes 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 9.878 0.049 10.030 4.744 
SD 0.400 0.009 1.121 0.238 
VC 4.053 18.561 11.176 5.007 
B: LMWC gel (6.0%, w/w) with 1% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 10.269 0.046 10.334 4.271 
SD 1.134 0.005 0.506 0.668 
VC 11.038 11.230 4.900 15.650 
C: LMWC gel (6.0%, w/w) with 5% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 11.181 0.044 10.340 4.359 
SD 0.837 0.006 0.835 0.373 
VC 7.489 14.754 8.077 8.553 
D: LMWC gel (6.0%, w/w) with 10% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 12.071 0.033 9.183 4.702 
SD 0.688 0.009 0.695 0.379 
VC 5.699 26.784 7.572 8.050 
D: LMWC gel (6.0%, w/w) with 15% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 14.242 0.024 10.508 5.237 
SD 0.286 0.007 0.385 0.490 
VC 2.011 29.910 3.661 9.363 
 
The table shows maximum force (force 1), minimum force (force 2), area 1 and area 2. 
The values are the average (Ave) of 5 runs and are absolute. Measured with back-
extrusion equipment and 35 mm disc. Distance: 10 mm, speed 4 mm/sec.  
 
LMWC liposomal gels failed the accelerated stability test. The cohesivness was very low. 
The results presented in Table 9 cannot be scientifically evaluated. Next step would be to 
find out actually the time point when the gels start to degrade. As both the Table 9 and 
Figure 33 shows the HMWC gels were almost water like in consistence. All gels were 
















FIGURE 33: LIPOSOMAL LMWC GELS AFTER ACCELERATED STABILITY TESTING 
A: No liposomes; B: 1% (w/total) liposomes, C: 5% (w/total) liposomes; D: 10% 
(w/total) liposomes; E: 15% (w/total) liposomes. Measured with back-extrusion 


















FIGURE 34: THE APPEARANCE OF LIPOSOMAL LMWC GELS AFTER STABILITY TESTING 
A: No liposomes; B: 1% (w/total) liposomes, C: 5% (w7total) liposomes; D: 10% 
(w7total) liposomes; E: 15% (w/total) liposomes 
 
There were little differences between the appearance of liposomal hydrogels and the 









Medium molecular weight chitosan hydrogels after one month storage at 40 °C 
TABLE 10: MMWC GELS AFTER ACCELERATED STABILITY TEST 
A: MMWC gel (3.5%, w/w) without liposomes 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 59.226 113.041 42.075 93.310 
SD 0.593 0.721 0.288 0.530 
VC 1.001 0.638 0.685 0.568 
B: MMWC gel (3.5%, w/w) with 1% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 51.019 95.132 35.149 77.191 
SD 0.275 0.690 0.379 0,566 
VC 0.538 0.725 1.077 0,734 
C: MMWC gel (3.5%, w/w) with 5% (w/w) liposomes in gel  
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 4.836 87.554 33.977 71.479 
SD 0.427 1.209 0.697 0.628 
VC 1.020 1.380 2.051 0.878 
D: MMWC gel (3.5%, w/w) with 10% (w/w) liposomes in gel  
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 15.219 0.022 10.964 6.578 
SD 0.346 0.012 0.418 0.436 
VC 2.274 56.416 3.809 6.627 
D: MMWC gel (3.5%; w/w) with 15% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 16.413 0.001 11.810 6.585 
SD 0.397 0.020 0.221 0.316 
VC 2.417 3657.321 1.875 4.806 
 
The table shows maximum force (force 1), minimum force (force 2), area 1 and area 2. 
The values are the average (Ave) of 5 runs and are absolute. Measured with back-
extrusion equipment and 35 mm disc. Distance: 10 mm, speed 4 mm/sec. 
 
The MMWC liposomal gels performed better during the accelerated stability test. The 
empty gel, 1% (w/w) liposomal gel and the 5% (w/w) liposomal gel were firm and 
maintained the original consistency during the accelerated stability testing.  
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The Figure 35 also shows that first three gels maintain most of the original degree of 













FIGURE 35: LIPOSOMAL MMWC GELS AFTER ACCELERATED STABILITY TESTING 
A: No liposomes; B: 1% (w/total) liposomes, C: 5% (w/total) liposomes; D: 10% 
(w/total) liposomes; E: 15% (w/total) liposomes. Measured with back-extrusion 


















FIGURE 36: THE APPEARANCE OF LIPOSOMAL MMWC GELS AFTER STABILITY TESTING 
A: No liposomes; B: 1% (w/total) liposomes, C: 5% (w/total) liposomes; D: 10% 
(w/total) liposomes; E: 15% (w/total) liposomes 
 
The MMWC gels appeared to be slightly darker yellow in colour than prior to the 
stability testing. Two possible suggestions for the decomposition of the hydrogels can be 
liposomal disintegration or chitosan breakdown. It would be interesting to compare the 
10% and 15% MMWC liposomal hydrogels with adjusted chitosan concentration after 
added liposomes. If gels were prepared at a higher concentrations adjusting for the 
liposomal concentration, lesser decomposition might occur. The colour after stability test 
was a little closer to the LMWC gels before the test. When considering that the colour of 
the MMWC gels appeared more like the colour of LMWC gels, one might suggest that a 




High molecular weight chitosan hydrogels after one month storage at 40 °C 
 
TABLE 11: HMWC GELS AFTER ACCELERATED STABILITY TEST  
A: HMWC gel (2.5%, w/w) without liposomes 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 51.844 87.586 33.933 63.484 
SD 0.745 1.602 1.170 2.688 
VC 1.436 1.829 3.449 4.234 
B: HMWC gel (2.5%, w/w) with 1% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 15.024 0.024 10.312 6.610 
SD 0.312 0.007 0.370 0.353 
VC 2.074 28.418 3.585 5.347 
C: HMWC gel (2.5%, w/w) with 5% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 9.987 0.052 10.920 4.393 
SD 0.783 0.005 0.769 0.339 
VC 7.838 9.080 7.046 7.725 
D: HMWC gel (2.5%, w/w) with 15% (w/w) liposomes in gel 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 9.813 0.062 11.767 4.040 
SD 1.286 0.006 0.577 0.512 
VC 13.100 9.669 4.902 12.677 
 
The table shows maximum force (force 1), minimum force (force 2), area 1 and area 2. 
The values are the average (Ave) of 5 runs and are absolute. Measured with back-
extrusion equipment and 35 mm disc. Distance: 10 mm, speed 4 mm/sec. 
 
As can be seen in Table 11 and Figure 37, the empty HMWC gels remain to keep some 
of the gel matrix intact after the stability test. Moreover, HMWC gels can be prepared at 
higher concentrations than 2.5% (w/w) so that this type of hydrogels have the potential to 













FIGURE 37: LIPOSOMAL MMWC GELS AFTER ACCELERATED STABILITY TESTING 
A: No liposomes; B: 1% (w/total) liposomes, C: 5% (w/total) liposomes; D: 15% 
(w/total) liposomes. Measured with back-extrusion equipment and 35 mm disc. Distance: 
















FIGURE 38: THE APPEARANCE OF LIPOSOMAL HMWC GELS AFTER STABILITY TESTING 
A: No liposomes; B: 1% (w/total) liposomes, C: 5% (w/total) liposomes; D: 15% 
(w/total) liposomes 
 
HMWC liposomal gels become more yellow after the stability test. However, empty gel 
(without liposomes) hardly changed its original colour. 
 
 
5.2.2. Accelerated stability testing of chitosan hydrogels containing glycerine 
It is well known fact that glycerine can prevent dehydration of various gel types (Mourtas 
et al., 2008). In our case as well, glycerine was added to prevent water evaporation seen 
on the (para-film) cover used to prevent dehydration of the gel. Glycerine is also known 
to function as a co-solvent for incorporated active ingredients. HMWC was found to be 
the most suitable gelling agent among the tested chitosan types. HMWC gel was prepared 
with 1% glycerine and liposomes incorporated as can be seen in Table 12. In the case of 
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empty gel, the glycerine slightly lowered the gel cohesivness. When comparing Table 12 
and Table 13, the effect of added glycerine is apparent.  
 
TABLE 12: HMWC GELS CONTAINING GLYCERINE BEFORE ACCELERATED STABILITY TESTING   
A: HMWC gel (2.5%, w/w) without liposomes, with 1% (w/w) glycerine 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 183.170 359.149 130.892 285.028 
SD 1.893 1.979 0.674 1.392 
VC 1.034 0.551 0.515 0.488 
B: HMWC gel (2.5%, w/w) with 1% (w/w) liposomes, 1% (w/w) glycerine 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 174.725 345.655 125.312 278.140 
SD 3.432 4.101 0.564 0.378 
VC 1.964 1.186 0.450 0.136 
C: HMWC gel (2.5%, w/w) with 5% (w/w) liposomes, 1% (w/w) glycerine 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 155.902 311.944 113.241 252.189 
SD 1.294 0.209 0.359 0.897 
VC 0.830 0.067 0.317 0.356 
D: HMWC gel (2.5%, w/w) with 10% (w/w) liposomes, 1% (w/w) glycerine 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 136.971 271.979 99.368 221.577 
SD 0.909 1.317 0.757 1.257 
VC 0.664 0.484 0.762 0.567 
 
The table shows maximum force (force 1), minimum force (force 2), area 1 and area 2. 
The values are the average (Ave) of 5 runs and are absolute. Measured with back-
extrusion equipment and 35 mm disc. Distance: 10 mm, speed 4 mm/sec. 
 
The incorporation of glycerine also affected the difference between liposomal HMWC 













FIGURE 39: HMWC LIPOSOMAL HYDROGELS WITH ADDED 1% GLYCERINE BEFORE STABILITY 
TESTING 
A: No liposomes; B: 1% (w/total) liposomes, C: 5% (w/total) liposomes. Measured with 
back-extrusion equipment and 35 mm disc. Distance: 10 mm, speed 4 mm/sec, 5 runs. 
Measured with back-extrusion equipment and 35 mm disc. Distance: 10 mm, speed 4 
mm/sec, 5 runs. 
 
 
Table 13 reveals that glycerine indeed stabilized HMWC gels but especially strong 
impact was seen on the liposomal gels. The gels maintained some of the original texture 
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properties. A stability test at room temperature to get more accurate insight on how stable 
the gels are at expected storage conditions would be the next step.  
 
TABLE 13: HMWC GELS CONTAINING GLYCERINE AFTER ACCELERATED STABILITY TEST 
A: HMWC 2.5% (w/w) with no liposomes and 1% (w/w) glycerine 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 84.647 162.179 59.984 130,816 
SD 0.359 0.861 0.709 0.413 
VC 0.425 0.531 1.182 0.316 
B: HMWC 2.5% (w/w) with 1% (w/w) liposomes and 1% (w/w) glycerine 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 44.397 83.296 31.740 67.281 
SD 0.743 0.826 1.076 0.481 
VC 1.673 0.992 3.390 0.715 
C: HMWC 2.5% (w/w) with 5% liposomes and 1% (w/w) glycerine 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 49.846 103.251 39.772 80.925 
SD 0.525 1.110 0.754 0.929 
VC 1.053 1.075 1.896 1.147 
D: HMWC 2.5% (w/w) with 10% (w/w) liposomes and 1% (w/w) glycerine 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 35.279 59.484 21.688 44.481 
SD 1.890 1.059 0.584 0.937 
VC 5.358 1.781 2.693 2.107 
 
The table shows maximum force (force 1), minimum force (force 2), area 1 and area 2. 
The values are the average (Ave) of 5 runs and are absolute. The liposomal dispersion 
was containing 0.2% (w/w) chloramphenicol. Measured with back-extrusion equipment 















FIGURE 40: HMWC LIPOSOMAL GELS CONTAINING GLYCERINE AFTER ACCELERATED STABILITY 
TESTING 
A: No glycerine, no liposomes; B: No glycerine, 10% (w/total) liposomes; C: 1% (w/w) 
glycerine, 10% (w/total) liposomes; D: 1% (w/w) glycerine, 10% (w/total) liposomes. 
Measured with back-extrusion equipment and 35 mm disc. Distance: 10 mm, speed 4 




5.2.3. Stability testing in freezing conditions 
HMWC hydrogels (2.5% w/w) with or without added glycerine and with and without 
incorporated liposomes were evaluated in freezing conditions. The stock gels were bath 
sonicated over two hours prior to the testing, which might explain why the texture 
property is different (Table 14) as compared to previous results with the same 
preparation. The cohesiveness of the empty gel without glycerine was found to be higher 
after freezing and thawing. With the liposomal hydrogel without glycerine the cohesive 
forces (area 1) went up and adhesive forces (area 2) went down. Even though the results 
are near. This showed that something happened to the gel matrix. Both the empty 
hydrogel with glycerine and the liposomal hydrogel with glycerine showed increased area 
1 and area 2 (Table 15). That indicates that freezing combined with glycerine in the 
formulation increases the stability. Further analyses of the gel structure needs to be done 
to confirm that the gels can tolerate freezing. However, the freezing did not lower the 
viscosity in the gels tested, rather the opposite. Yang et al. (2009) describes that freeze-
thaw method and irradiation method in combination is suitable to yield stable gels. 












TABLE 14: STABILITY OF HMWC GELS PRIOR TO FREEZING 
A: HMWC gel (2.5%, w/w) without liposomes, without glycerine 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 132.148 299.767 118.232 241.694 
SD 1.119 2.773 0.957 0.580 
VC 0.847 0.925 0.810 0.240 
B: HMWC gel (2.5%, w/w) with 10% (w/w) liposomes, without glycerine 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 100.191 223.835 86.492 182.788 
SD 0.602 0.638 0.463 0.604 
VC 0.601 0.285 0.535 0.330 
C: HMWC gel (2.5%, w/w) without liposomes, 1% (w/w) glycerine 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 144.457 328.682 128.349 262.303 
SD 1.337 1.580 0.808 0.507 
VC 0.926 0.481 0.630 0.193 
D: HMWC gel (2.5%, w/w) with 10% (w/w) liposomes, 1% (w/w) glycerine 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 130.563 290.056 111.654 233.375 
SD 1.086 0.563 0.709 1.133 
VC 0.832 0.194 0.635 0.485 
 
The table shows maximum force (force 1), minimum force (force 2), area 1 and area 2. 
The values are the average (Ave) of 5 runs and are absolute. Measured with back-















FIGURE 41: HMWC GELS PRIOR TO FREEZING 
A: No glycerine, no liposomes; B: No glycerine, 10% (w/total) liposomes; C: 1% (w/w) 
glycerine, 10% (w/total) liposomes; D: 1% (w/w) glycerine, 10% (w/total) liposomes. 
Measured with back-extrusion equipment and 35 mm disc. Distance: 10 mm, speed 4 







TABLE 15: STABILITY UPON FREEZING AND THAWING 
E: HMWC gel (2.5%, w/w) without liposomes, without glycerine 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 184.560 365.799 131.196 291.932 
SD 2.140 1.457 1.438 0.989 
VC 0.847 0.398 1.096 0.339 
F: HMWC gel (2.5%, w/w) with 10% (w/w) liposomes, without glycerine 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 104.383 230.994 88.035 179.954 
SD 1.465 2.229 1.092 0.521 
VC 1.404 0.965 1.240 0.289 
G: HMWC gel (2.5%, w/w) without liposomes, 1% (w/w) glycerine 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 159.267 350.517 132.477 274.519 
SD 2.097 0.872 0.776 0.422 
VC 1.317 0.249 0.585 0.154 
H: HMWC gel (2.5%, w/w) with 10% (w/w) liposomes, 1% (w/w) glycerine 
 Force 1 (g) Area 1 (g·sec) Force 2 Area 2 (g·sec) 
Ave 126.354 280.418 106.207 218.198 
SD 1.886 0.919 0.912 0.637 
VC 1.493 0.328 0.859 0.292 
 
The table shows maximum force (force 1), minimum force (force 2), area 1 and area 2. 
The values are the average (Ave) of 5 runs and are absolute. Measured with back-
















FIGURE 42: STABILITY UPON FREEZING AND THAWING 
A: No glycerine, no liposomes; B: No glycerine, 10% (w/total) liposomes; C: 1% (w/w) 
glycerine, 10% (w/total) liposomes; D: 1% (w/w) glycerine, 10% (w/total) liposomes. 
Measured with back-extrusion equipment and 35 mm disc. Distance: 10 mm, speed 4 
mm/sec, 5 runs.  
The freeze-thawing experiment showed that the cohesiveness of the gel increased. It is 
possible that the reinforcement of the hydrogel matrix can have occurred (Yang et al., 
2009). It is known that liposomes are sensitive to the freezing process, however, as 
liposomes were incoporated in gels, it is expected that the gel provide a protection to 
liposomes from outer conditions (Pavelic et al., 2001). 
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5.3. In vitro release rate 
 
5.3.1. Entrapment efficiency determination and particle size analysis 
Prior to incorporation of liposomes in hydrogels, liposomal size, size distributions and 
chloramphenicol entrapment values were determined. The results are presented in Table 
16. 
TABLE 16: THE CHARACTERISTICS OF LIPOSOMES CONTAINING CHLORAMPHENICOL 
Lipid (mg) Particle 


















During the process of separation of liposomally entrapped drug and free drug 
(ultracentrifugation), we observed that the supernatant, which would normally not contain 
liposomes as we prepared MLVs by the film method, also contained very small particles. 
This was further confirmed by the PCS measurements, where clear distinctions could be 
seen between very small and much larger vesicle, resulting in higher PI (0.637) values as 
well. Due to this fact, for preparation of liposomal hydrogles we used liposomal 
dispersion containing both liposomal and unentrapped (free) chloramphenicol as 
entrapment was found to be rather high. This high entrapment is in agreement with 
Škalko et al. (1998) who proved that encapsulation values are higher for larger 
liposomes. In their study of liposomes containing metronidazole, the median size of 300 
nm liposomes gave the highest drug entrapment values, providing the reservoir for drug 
in the deeper skin layers. 
 
5.3.2. Standard curve HPLC 
The standard curve was made by the concentrations: 2, 5, 8, 25 and 50 μg/ml 
chloramphenicol in methanol. 
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Equation for standard curve: Y = X ⋅ 1.57⋅ 104 + 6.93⋅ 103 
 
5.3.3. HPLC analysis 
TABLE 17: IN VITRO RELEASE STUDY 
Sample Time 
(min) 
Area  Amount of drug in 
acceptor medium (μg) 
% release  
1 5 3094.0 - - 
2 10 6632.5 - - 
3 15 10822.0 11.636 0.232 
4 25 18849.5 35.667 0.714 
5 35 23517.5 49.344 0.986 
6 45 25369.5 54.652 1.094 
7 60 36495.5 85.831 1.716 
8 75 46635.5 113.605 2.272 
9 90 54575.0 134.845 2.697 
10 180 56337.5 139.448 2.788 
11 300 70560.5 175.685 3.514 
 
HMWC gel 2.5% (w/w) with 10% (w/w) of added liposomal dispersion containing 
chloramphenicol was used in testing. The results are an average of two determinations. 
The drug concentration was determined by the HPLC analysis. The measurement 
conditions were: Mobile phase was 45% methanol, 55% filtered H2O and 0.1% acetic 
acid (glacial). Temperature of samples and column was 35 °C. Flow rate was 1 ml/min. 
Running time for each sample was 5 minute and picks were monitored at UV 270 nm. 
Total amount of chloramphenicol in gel was 5 mg, acceptor medium: middle chain 
triglycerids, polyamid membrane and 1 ml sample size. The table shows the amount of 
chloramphenicol in the acceptor medium after given time intervals. The values are 





FIGURE 43: PERCENTAGE RELEASE (CUMULATIVE) OF CHLORAMPHENICOL 
Data from release study. X-axis is showing the time elapsed. The Y-axis is showing the 
release in percent of total amount (cumulative). 
The results are an average of two determinations. The drug concentration was determined 
by the HPLC analysis. The measurement conditions were: Mobile phase was 45% 
methanol, 55% filtered H2O and 0.1% acetic acid (glacial). Temperature of samples and 
column was 35 °C. Flow rate was 1 ml/min. Running time for each sample was 5 minute 
and peaks were monitored at UV 270 nm. The values are cumulative and adjusted for the 
decreasing amount of acceptor medium during sampling. 
 
Figure 43 and Table 17 show that the release of chloramphenicol was quite linear up to 
90 minutes during the release study. The release was continuing up to 300 minutes when 
the last sample was taken. We realized that the experimental set up should include 
minimum 24 hours sampling and the current measurement continues with sampling for 
24 hours. Chloramphenicol in our case was both distributed in liposomes and liposomal 
dispersion medium. The initial release can be a combination of release from both. 
Liposomes are known for prolonging the drug release. Panduranga Rao and Alamelu 
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(1992) studied the release of an aqueous marker from liposomes and liposomes in 
chitosan. They found that liposomes prolonged the release compared to release from 
hydrogel alone. And adding increasing amounts of a cross-linking agent even further 
prolonged the release. Drugs entrapped into liposomes function as depot formulations 
(Jagur-Grodzinski, 2009). Around 19 percent of the chloramphenicol was entrapped in 
the small liposomes or dissolved in the liposomal dispersion phase. The release was 
expected to be faster from chloramphenicol dissolved in the dispersion phase. Therefore, 
faster release initially was to be expected. Although chloramphenicol could be dissolved 
into hydrogels alone, liposomes containing chloramphenicol can be preferable. Drugs 
incorporated into liposomal hydrogels give a retarded release compared to drugs 
dissolved in a hydrogel (Ruel-Gariépy et al., 2002). Since chitosan preparations for 
wound healing should be left on the skin for hours and maybe up to 24 hours or more, a 















Chitosan hydrogels  for wound healing were prepared  from  low, medium and high 
molecular  weight  chitosan.  The  preferred  concentrations  of  chitosan  in  the  gels 
were  6%  (w/w)  for  low  molecular  weight,  3.5%  (w/w)  for  medium  molecular 
weight  and  2.5%  (w/w)  for  high  molecular  weight.  The  high  molecular  weight 
chitosan was the optimal because it could be prepared at lower concentrations and 
still maintain an acceptable viscosity. 
A  method  for  evaluating  and  comparing  texture  properties  of  hydrogels  was 
established with  the Texture  analyser  and  back‐extrusion  equipment.  Gels  can  be 
analysed  in  minutes  and  the  method  was  reproducible  with  standard  deviations 
varying  with  less  than  2%.  This  makes  it  applicable  in  comparing  variations 
between different batches of gels as well as the stability.  
Stability was  tested with  the  preferred  concentrations  of  chitosan  gels  as well  as 
liposomal gels. Accelerated stability tests proved that chitosan gels are not stable for 
30  days  at  40  °C.  The  viscosity  increased  after  one  freeze‐thaw  cycle  for  high 
molecular  chitosan  gel.  Liposomal  dispersion  added  to  the  gels  made  them  less 
viscous  and  less  stable.  The  addition  of  1%  (w/w)  glycerine  prepared  with  high 
molecular  weight  chitosan  made  the  gels  more  stable.  Especially  liposomal 
hydrogels proved to be more stable when glycerine was in the gel.  
Liposomal  chitosan  gels  were  prepared  with  chloramphenicol  as  a  model  drug. 
Release was  tested  on  in  vitro  release model  and  quantified  by  HPLC.  Liposomal 
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to  evaluate  gel  stability.  The  effect  of  gel  type  on  release  pattern  of  liposomally 
entrapped model drug, chloramphenicol, was studied in an in vitro model for topical 
release. 
Results: Both gel  concentration and pH have direct  influence on  the viscosity and 
bioadhesivness  of  hydrogels.  Carbopol  hydrogels  remained  stable  at  accelerated 
stability  conditions,  whereas  chitosan  hydrogels  did  not  resistant  temperature 
increase. However, glycerol  improved  the stability of chitosan gels  to great extent. 
Release  of  liposomally  entrapped  drug  was  found  to  be  slower  from  chitosan 
hydrogels as co  mpared to Carbopol hydrogels.
Conclusions: Gel  adhesiveness,  stability  and  the  release  of  incorporated  drug  are 
recommended as the main features influencing the choice of gel‐forming material in 
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Aim:  Retention  time  of wound dressing  at  the  application  site will  determine  the 
efficacy of the wound treatment. The choice of a hydrogel matrix and a drug carrier 
system  has  direct  influence  on  the  effectiveness  of  a  topical  gel  formulation.  To 






Analyser  (Stable  Micro  Systems  Ltd.,  UK).  Texture  properties,  including 
bioadhesiveness  were  evaluated  and  compared.  Accelerated  stability  testing  was 




Results and Discussion:  Both  gel  concentration  and  pH  have  direct  influence  on 
the viscosity and bioadhesivness of hydrogels. Carbopol hydrogels remained stable 
at  accelerated  stability  conditions,  whereas  chitosan  hydrogels  did  not  resistant 
temperature  increase. However, glycerol  improved  the stability of chitosan gels  to 
great  extent.  Release  of  liposomally  entrapped drug was  found  to  be  slower  from 
hitosan hydrogels as compared to Carbopol hydrogels. c
 
Conclusion:  The  choice  of  a  certain  gel  matrix  and  the  adjustment  of  the 
technological characteristics affects the properties of a topical gel  formulation to a 
great extent. Adhesiveness and drug release are  two of  the main properties which 
can  be  influenced  by  that.  Chitosan  and  carbopol  are  suitable  model  matrices  to 
analyse  the  effect  of  different  impacts  towards  the  abilities  of  the  hydrogel 
ormulation. 
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